SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-23-124376
Filing Date
2023-04-28
Accepted
2023-04-28 08:00:57
Documents
12
Period of Report
2023-04-24
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d472000d8k.htm   iXBRL 8-K 25435
  Complete submission text file 0001193125-23-124376.txt   143532

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA anik-20230424.xsd EX-101.SCH 2844
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE anik-20230424_lab.xml EX-101.LAB 17235
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE anik-20230424_pre.xml EX-101.PRE 10808
6 EXTRACTED XBRL INSTANCE DOCUMENT d472000d8k_htm.xml XML 3274
Mailing Address 32 WIGGINS AVENUE BEDFORD MA 01730
Business Address 32 WIGGINS AVENUE BEDFORD MA 01730 (781) 457-9000
Anika Therapeutics, Inc. (Filer) CIK: 0000898437 (see all company filings)

IRS No.: 043145961 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-14027 | Film No.: 23860261
SIC: 3841 Surgical & Medical Instruments & Apparatus